Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer

– Clinicians agree that evidence supports testing benefits for all – SAN FRANCISCO, Sept. 15, 2022 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, joined other clinical experts in releasing a new commentary in Journal of Clinical Oncology Precision Oncology,…